Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16632 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-763 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2008-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-WO2005094867-A1 |
titleOfInvention |
Anti-cancer effect enhancer for viral therapy, cancer prevention or treatment method |
abstract |
The present invention provides a drug that effectively and safely enhances the anticancer action of virus therapy, particularly antitumor immunity, and a method for preventing or treating cancer using this drug. The anticancer activity enhancer according to the present invention contains interleukin as an active ingredient, which is administered in combination with a recombinant herpes simplex virus that selectively replicates cancer cells. |
priorityDate |
2004-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |